​

Working at the interface of material science, chemistry, biology, and biomedical engineering, we aim to promote healthy aging with a materials-centric approach, to innovate the treatments for degenerative diseases. Our research focuses on translational strategies to develop gene therapies for neurological disorders or chronic diseases.